{"id":25578,"date":"2026-06-09T00:00:00","date_gmt":"2026-06-09T00:00:00","guid":{"rendered":"https:\/\/angelboss.com.br\/2026\/06\/09\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\/"},"modified":"2026-06-09T00:00:00","modified_gmt":"2026-06-09T00:00:00","slug":"332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral","status":"publish","type":"post","link":"https:\/\/angelboss.com.br\/en\/2026\/06\/09\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\/","title":{"rendered":"Shilpa Medicare e Gate2Brain assinam parceria estrat\u00e9gica de capital para avan\u00e7ar na terapia pioneira contra o c\u00e2ncer cerebral"},"content":{"rendered":"<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA Shilpa Biocare Pvt. Ltd., subsidi\u00e1ria da Shilpa Medicare Limited (BSE\/NSE: SHILPAMED), firmou uma parceria estrat\u00e9gica de capital com a Gate2Brain S.L., empresa de biotecnologia focada em terapias para o sistema nervoso central (SNC). Com a parceria, a Shilpa se torna acionista estrat\u00e9gica e parceira em CMC, fabrica\u00e7\u00e3o e regulamenta\u00e7\u00e3o para o G2B-002, o principal programa da Gate2Brain voltado para os c\u00e2nceres cerebrais pedi\u00e1tricos fatais DIPG e pGBM, ambos com <b>Designa\u00e7\u00e3o de Medicamento \u00d3rf\u00e3o<\/b> da FDA dos EUA e da EMA. O G2B-002 utiliza o transportador pept\u00eddico MiniAp4, de propriedade da Gate2Brain, para administrar o SN-38 atrav\u00e9s da barreira hematoencef\u00e1lica, demonstrando, em estudos pr\u00e9-cl\u00ednicos, um transporte do f\u00e1rmaco para o c\u00e9rebro at\u00e9 100 vezes maior. Os primeiros ensaios em humanos est\u00e3o previstos para o ano fiscal de 2028.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nO G2B-002 tem como alvo mercados oncol\u00f3gicos de alto crescimento, como o de glioblastoma, projetado para chegar a US$ 6,48 bilh\u00f5es at\u00e9 2035 (CAGR de 7,97%), o de tumores cerebrais pedi\u00e1tricos, estimado em US$ 2,47 bilh\u00f5es at\u00e9 2031 (CAGR de 6,9%), e o de DIPG, estimado em US$ 1,2 bilh\u00e3o at\u00e9 2035 (CAGR de 7,1%). A plataforma MiniAp4 da Gate2Brain amplia ainda mais o potencial em c\u00e2nceres pedi\u00e1tricos raros e em categorias mais amplas do SNC. Essa \u00e9 a quarta parceria estrat\u00e9gica de capital da Shilpa, que reafirma seu compromisso com a inova\u00e7\u00e3o diferenciada e a cria\u00e7\u00e3o de valor de longo prazo para acionistas e sociedade.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><b>Coment\u00e1rios da Administra\u00e7\u00e3o<\/b><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><b>Vishnukant Bhutada, diretor-geral da Shilpa Medicare Ltd:<\/b><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><i>\u201cA tecnologia de travessia da barreira hematoencef\u00e1lica da Gate2Brain est\u00e1 entre as plataformas de entrega ao sistema nervoso central (SNC) mais diferenciadas que avaliamos. Tornar-nos acionistas estrat\u00e9gicos permite que a Shilpa participe da cria\u00e7\u00e3o de valor de longo prazo, ao mesmo tempo em que contribui com a expertise em fabrica\u00e7\u00e3o e assuntos regulat\u00f3rios necess\u00e1ria para levar o G2B-002 aos estudos de primeira administra\u00e7\u00e3o em humanos e ampliar sua aplica\u00e7\u00e3o para outras mol\u00e9culas e categorias terap\u00eauticas.\u201d<\/i><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><b>Meritxell Teixid\u00f3 Tur\u00e0, CEO da Gate2Brain:<\/b><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><i>\u201cEsta parceria proporciona ao G2B-002 um caminho claro e com riscos reduzidos at\u00e9 a fase cl\u00ednica e valida nossa plataforma de pept\u00eddeos transportadores com um parceiro oncol\u00f3gico de primeira linha. Alinhar as capacidades de fabrica\u00e7\u00e3o e regulamenta\u00e7\u00e3o da Shilpa &agrave; nossa ci\u00eancia \u00e9 a estrutura adequada para levar este programa \u2014 e os pr\u00f3ximos \u2014 aos pacientes.\u201d<\/i><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><b>Sobre a Shilpa Medicare Ltd<\/b><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nL\u00edder entre as empresas farmac\u00eauticas indianas, a <strong>Shilpa Medicare Limited<\/strong> foca no desenvolvimento, na fabrica\u00e7\u00e3o e na comercializa\u00e7\u00e3o de APIs (Ingredientes Farmac\u00eauticos Ativos), formula\u00e7\u00f5es e produtos biol\u00f3gicos nas \u00e1reas de oncologia, doen\u00e7as infecciosas e especialidades. Com expertise em gen\u00e9ricos complexos, sistemas inovadores de administra\u00e7\u00e3o de medicamentos e servi\u00e7os de CDMO (Organiza\u00e7\u00e3o de Desenvolvimento e Fabrica\u00e7\u00e3o Contratada), a Shilpa atende pacientes em mais de 80 pa\u00edses. Para informa\u00e7\u00f5es adicionais, acesse <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.vbshilpa.com&amp;esheet=54548084&amp;newsitemid=20260605275999&amp;lan=pt-BR&amp;anchor=www.vbshilpa.com&amp;index=1&amp;md5=38e76b6222f52a6baa11707071253c3e\" rel=\"follow\" shape=\"rect\" target=\"_blank\">www.vbshilpa.com<\/a><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><b>Sobre a Gate2Brain, S.L.<\/b><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA Gate2Brain, empresa de biotecnologia sediada em Barcelona, desenvolve sistemas de administra\u00e7\u00e3o baseados em pept\u00eddeos para transportar terapias atrav\u00e9s da barreira hematoencef\u00e1lica e tratar doen\u00e7as do sistema nervoso central. Seu principal candidato, o G2B-002, utiliza o sistema patenteado de transporte de pept\u00eddeos MiniAp4 para entregar cargas oncol\u00f3gicas diretamente em tumores cerebrais. <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.gate2brain.com&amp;esheet=54548084&amp;newsitemid=20260605275999&amp;lan=pt-BR&amp;anchor=www.gate2brain.com&amp;index=2&amp;md5=366b0cc52e8578dc8cb4c1f5bb336751\" rel=\"follow\" shape=\"rect\" target=\"_blank\">www.gate2brain.com<\/a><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nO texto no idioma original deste an\u00fancio \u00e9 a vers\u00e3o oficial autorizada. As tradu\u00e7\u00f5es s\u00e3o fornecidas apenas como uma facilidade e devem se referir ao texto no idioma original, que \u00e9 a \u00fanica vers\u00e3o do texto que tem efeito legal.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260605275999r1&amp;sid=brdno&amp;distro=ftp\"><span class=\"bwct31415\"><\/span><\/p>\n<p id=\"mmgallerylink\" xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><span id=\"mmgallerylink-phrase\">Ver a vers\u00e3o original em businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260605275999\/pt\/\" rel=\"follow\" target=\"_blank\">https:\/\/www.businesswire.com\/news\/home\/20260605275999\/pt\/<\/a><\/span><\/p>\n<p><b>Contato:<\/b><\/p>\n<p>\nContato de imprensa da Shilpa Medicare\n<\/p>\n<p>Sr. Monish Shah \u2013 <a href=\"mailto:mediarelations@vbshilpa.com\" rel=\"follow\" shape=\"rect\">mediarelations@vbshilpa.com<\/a><\/p>\n<p><strong>Fonte: <\/strong><a href='http:\/\/www.businesswire.com\/portal\/site\/home\/' target='_blank'>BUSINESS WIRE<\/a><img src='https:\/\/api.dino.com.br\/v2\/news\/tr\/332296?partnerId=4593' alt=\"\" style=\"border:0px;width:1px;height:1px;\" \/><\/p>","protected":false},"excerpt":{"rendered":"<p>A Shilpa Biocare Pvt. Ltd., subsidi\u00e1ria da Shilpa Medicare Limited (BSE\/NSE: SHILPAMED), firmou uma parceria estrat\u00e9gica de capital com a Gate2Brain S.L., empresa de biotecnologia focada em terapias para o sistema nervoso central (SNC). Com a parceria, a Shilpa se torna acionista estrat\u00e9gica e parceira em CMC, fabrica\u00e7\u00e3o e regulamenta\u00e7\u00e3o para o G2B-002, o principal<\/p>","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[315],"tags":[324,352,351,323],"class_list":["post-25578","post","type-post","status-publish","format-standard","category-noticias-corporativas-dino","tag-negocios","tag-saude-e-bem-estar","tag-sociedade","tag-tecnologia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Shilpa Medicare e Gate2Brain assinam parceria estrat\u00e9gica de capital para avan\u00e7ar na terapia pioneira contra o c\u00e2ncer cerebral - Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/angelboss.com.br\/en\/2026\/06\/09\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shilpa Medicare e Gate2Brain assinam parceria estrat\u00e9gica de capital para avan\u00e7ar na terapia pioneira contra o c\u00e2ncer cerebral - Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss\" \/>\n<meta property=\"og:description\" content=\"A Shilpa Biocare Pvt. Ltd., subsidi\u00e1ria da Shilpa Medicare Limited (BSE\/NSE: SHILPAMED), firmou uma parceria estrat\u00e9gica de capital com a Gate2Brain S.L., empresa de biotecnologia focada em terapias para o sistema nervoso central (SNC). Com a parceria, a Shilpa se torna acionista estrat\u00e9gica e parceira em CMC, fabrica\u00e7\u00e3o e regulamenta\u00e7\u00e3o para o G2B-002, o principal\" \/>\n<meta property=\"og:url\" content=\"https:\/\/angelboss.com.br\/en\/2026\/06\/09\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\/\" \/>\n<meta property=\"og:site_name\" content=\"Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-09T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260605275999r1&amp;sid=brdno&amp;distro=ftp\" \/>\n<meta name=\"author\" content=\"DINO\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DINO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/06\\\/09\\\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/06\\\/09\\\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\\\/\"},\"author\":{\"name\":\"DINO\",\"@id\":\"http:\\\/\\\/angelboss.com.br\\\/en\\\/#\\\/schema\\\/person\\\/b6676b8d991f97199ef2d5b8e5c2d8a5\"},\"headline\":\"Shilpa Medicare e Gate2Brain assinam parceria estrat\u00e9gica de capital para avan\u00e7ar na terapia pioneira contra o c\u00e2ncer cerebral\",\"datePublished\":\"2026-06-09T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/06\\\/09\\\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\\\/\"},\"wordCount\":683,\"commentCount\":0,\"publisher\":{\"@id\":\"http:\\\/\\\/angelboss.com.br\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/06\\\/09\\\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260605275999r1&amp;sid=brdno&amp;distro=ftp\",\"keywords\":[\"NEG\u00d3CIOS\",\"SA\u00daDE E BEM-ESTAR\",\"SOCIEDADE\",\"TECNOLOGIA\"],\"articleSection\":[\"Not\u00edcias Corporativas\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/06\\\/09\\\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/06\\\/09\\\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\\\/\",\"url\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/06\\\/09\\\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\\\/\",\"name\":\"Shilpa Medicare e Gate2Brain assinam parceria estrat\u00e9gica de capital para avan\u00e7ar na terapia pioneira contra o c\u00e2ncer cerebral - Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/angelboss.com.br\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/06\\\/09\\\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/06\\\/09\\\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260605275999r1&amp;sid=brdno&amp;distro=ftp\",\"datePublished\":\"2026-06-09T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/06\\\/09\\\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/06\\\/09\\\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/06\\\/09\\\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260605275999r1&amp;sid=brdno&amp;distro=ftp\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260605275999r1&amp;sid=brdno&amp;distro=ftp\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/angelboss.com.br\\\/2026\\\/06\\\/09\\\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"http:\\\/\\\/angelboss.com.br\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shilpa Medicare e Gate2Brain assinam parceria estrat\u00e9gica de capital para avan\u00e7ar na terapia pioneira contra o c\u00e2ncer cerebral\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\\\/\\\/angelboss.com.br\\\/en\\\/#website\",\"url\":\"http:\\\/\\\/angelboss.com.br\\\/en\\\/\",\"name\":\"Portal Masculino de Moda, Beleza, Luxo e Business - Angel Boss\",\"description\":\"O Maior Portal sobre Moda, Luxo, Beleza e Business Masculino do Brasil\",\"publisher\":{\"@id\":\"http:\\\/\\\/angelboss.com.br\\\/en\\\/#organization\"},\"alternateName\":\"Maior Portal e Blog de Beleza Masculina e Luxo\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\\\/\\\/angelboss.com.br\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"http:\\\/\\\/angelboss.com.br\\\/en\\\/#organization\",\"name\":\"Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss\",\"url\":\"http:\\\/\\\/angelboss.com.br\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\\\/\\\/angelboss.com.br\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/angelboss.com.br\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/WhatsApp-Image-2025-12-11-at-12.54.26.jpeg\",\"contentUrl\":\"https:\\\/\\\/angelboss.com.br\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/WhatsApp-Image-2025-12-11-at-12.54.26.jpeg\",\"width\":1280,\"height\":1280,\"caption\":\"Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss\"},\"image\":{\"@id\":\"http:\\\/\\\/angelboss.com.br\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"http:\\\/\\\/angelboss.com.br\\\/en\\\/#\\\/schema\\\/person\\\/b6676b8d991f97199ef2d5b8e5c2d8a5\",\"name\":\"DINO\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f29568383aedf96da155b6f87103b0e04b1c662f982055cda25086444ab33ff8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f29568383aedf96da155b6f87103b0e04b1c662f982055cda25086444ab33ff8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f29568383aedf96da155b6f87103b0e04b1c662f982055cda25086444ab33ff8?s=96&d=mm&r=g\",\"caption\":\"DINO\"},\"url\":\"https:\\\/\\\/angelboss.com.br\\\/en\\\/author\\\/DINO\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Shilpa Medicare e Gate2Brain assinam parceria estrat\u00e9gica de capital para avan\u00e7ar na terapia pioneira contra o c\u00e2ncer cerebral - Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/angelboss.com.br\/en\/2026\/06\/09\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\/","og_locale":"en_US","og_type":"article","og_title":"Shilpa Medicare e Gate2Brain assinam parceria estrat\u00e9gica de capital para avan\u00e7ar na terapia pioneira contra o c\u00e2ncer cerebral - Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss","og_description":"A Shilpa Biocare Pvt. Ltd., subsidi\u00e1ria da Shilpa Medicare Limited (BSE\/NSE: SHILPAMED), firmou uma parceria estrat\u00e9gica de capital com a Gate2Brain S.L., empresa de biotecnologia focada em terapias para o sistema nervoso central (SNC). Com a parceria, a Shilpa se torna acionista estrat\u00e9gica e parceira em CMC, fabrica\u00e7\u00e3o e regulamenta\u00e7\u00e3o para o G2B-002, o principal","og_url":"https:\/\/angelboss.com.br\/en\/2026\/06\/09\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\/","og_site_name":"Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss","article_published_time":"2026-06-09T00:00:00+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260605275999r1&amp;sid=brdno&amp;distro=ftp","type":"","width":"","height":""}],"author":"DINO","twitter_card":"summary_large_image","twitter_misc":{"Written by":"DINO","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/angelboss.com.br\/2026\/06\/09\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\/#article","isPartOf":{"@id":"https:\/\/angelboss.com.br\/2026\/06\/09\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\/"},"author":{"name":"DINO","@id":"http:\/\/angelboss.com.br\/en\/#\/schema\/person\/b6676b8d991f97199ef2d5b8e5c2d8a5"},"headline":"Shilpa Medicare e Gate2Brain assinam parceria estrat\u00e9gica de capital para avan\u00e7ar na terapia pioneira contra o c\u00e2ncer cerebral","datePublished":"2026-06-09T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/angelboss.com.br\/2026\/06\/09\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\/"},"wordCount":683,"commentCount":0,"publisher":{"@id":"http:\/\/angelboss.com.br\/en\/#organization"},"image":{"@id":"https:\/\/angelboss.com.br\/2026\/06\/09\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260605275999r1&amp;sid=brdno&amp;distro=ftp","keywords":["NEG\u00d3CIOS","SA\u00daDE E BEM-ESTAR","SOCIEDADE","TECNOLOGIA"],"articleSection":["Not\u00edcias Corporativas"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/angelboss.com.br\/2026\/06\/09\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/angelboss.com.br\/2026\/06\/09\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\/","url":"https:\/\/angelboss.com.br\/2026\/06\/09\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\/","name":"Shilpa Medicare e Gate2Brain assinam parceria estrat\u00e9gica de capital para avan\u00e7ar na terapia pioneira contra o c\u00e2ncer cerebral - Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss","isPartOf":{"@id":"http:\/\/angelboss.com.br\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/angelboss.com.br\/2026\/06\/09\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\/#primaryimage"},"image":{"@id":"https:\/\/angelboss.com.br\/2026\/06\/09\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260605275999r1&amp;sid=brdno&amp;distro=ftp","datePublished":"2026-06-09T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/angelboss.com.br\/2026\/06\/09\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/angelboss.com.br\/2026\/06\/09\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/angelboss.com.br\/2026\/06\/09\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260605275999r1&amp;sid=brdno&amp;distro=ftp","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260605275999r1&amp;sid=brdno&amp;distro=ftp"},{"@type":"BreadcrumbList","@id":"https:\/\/angelboss.com.br\/2026\/06\/09\/332296-shilpa-medicare-e-gate2brain-assinam-parceria-estrategica-de-capital-para-avancar-na-terapia-pioneira-contra-o-cancer-cerebral\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"http:\/\/angelboss.com.br\/en\/"},{"@type":"ListItem","position":2,"name":"Shilpa Medicare e Gate2Brain assinam parceria estrat\u00e9gica de capital para avan\u00e7ar na terapia pioneira contra o c\u00e2ncer cerebral"}]},{"@type":"WebSite","@id":"http:\/\/angelboss.com.br\/en\/#website","url":"http:\/\/angelboss.com.br\/en\/","name":"Portal Masculino de Moda, Beleza, Luxo e Business - Angel Boss","description":"O Maior Portal sobre Moda, Luxo, Beleza e Business Masculino do Brasil","publisher":{"@id":"http:\/\/angelboss.com.br\/en\/#organization"},"alternateName":"Maior Portal e Blog de Beleza Masculina e Luxo","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/angelboss.com.br\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"http:\/\/angelboss.com.br\/en\/#organization","name":"Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss","url":"http:\/\/angelboss.com.br\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/angelboss.com.br\/en\/#\/schema\/logo\/image\/","url":"https:\/\/angelboss.com.br\/wp-content\/uploads\/2025\/12\/WhatsApp-Image-2025-12-11-at-12.54.26.jpeg","contentUrl":"https:\/\/angelboss.com.br\/wp-content\/uploads\/2025\/12\/WhatsApp-Image-2025-12-11-at-12.54.26.jpeg","width":1280,"height":1280,"caption":"Portal Masculino de Moda, Beleza, Luxo and Business - Angel Boss"},"image":{"@id":"http:\/\/angelboss.com.br\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"http:\/\/angelboss.com.br\/en\/#\/schema\/person\/b6676b8d991f97199ef2d5b8e5c2d8a5","name":"DINO","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f29568383aedf96da155b6f87103b0e04b1c662f982055cda25086444ab33ff8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f29568383aedf96da155b6f87103b0e04b1c662f982055cda25086444ab33ff8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f29568383aedf96da155b6f87103b0e04b1c662f982055cda25086444ab33ff8?s=96&d=mm&r=g","caption":"DINO"},"url":"https:\/\/angelboss.com.br\/en\/author\/DINO\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/angelboss.com.br\/en\/wp-json\/wp\/v2\/posts\/25578","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/angelboss.com.br\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/angelboss.com.br\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/angelboss.com.br\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/angelboss.com.br\/en\/wp-json\/wp\/v2\/comments?post=25578"}],"version-history":[{"count":0,"href":"https:\/\/angelboss.com.br\/en\/wp-json\/wp\/v2\/posts\/25578\/revisions"}],"wp:attachment":[{"href":"https:\/\/angelboss.com.br\/en\/wp-json\/wp\/v2\/media?parent=25578"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/angelboss.com.br\/en\/wp-json\/wp\/v2\/categories?post=25578"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/angelboss.com.br\/en\/wp-json\/wp\/v2\/tags?post=25578"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}